Linda Eissenberg.jpg

Linda G. Eissenberg, PhD

Assistant Professor
Department of Medicine
Oncology Division
Stem Cell Biology

Research Interests

  • Gene therapy / suicide gene
  • Chimeric antigen receptor / bispecific targeting reagents
  • T cells
  • Leukemia / graft vs. host disease
  • Mobilization of hematopoietic stem cells
  • Chemosensitization by mobilizing leukemia cells


  • 314-362-7558 (tel)
  • 314-362-9333 (fax)
  • Room 626P Southwest Tower (lab)
  • Division of Oncology
    Campus Box 8007
    Washington University Medical School
    660 South Euclid Avenue
    St. Louis, MO 63110

Invited Publications

  • Suicide Genes: Monitoring Cells in Patients With a Safety Switch
    Eissenberg LG, Rettig M, Dehdashti F, Piwnica-Worms D, DiPersio JF
    Front Pharmacol 2014 Nov 6;5:241
  • BiTEs, DARTs, and CARs: Novel Targeted Therapies for Lymphoid Malignancies
    Eissenberg L, DiPersio JF
    Hematological Malignancies, Issue 10, Siteman Cancer Center, 2012: 1-2
  • Application of CXCR4 Inhibitors in Leukemia
    Ansstas G, Mir F, Rettig MP, Schroeder M, Eissenberg L, DiPersio JF
    Chapter 17, Novel Developments in Stem Cell Mobilization: Focus on CXCR4, 2012: 335-349
  • The Interplay Between Histoplasma Capsulatum and Its Host Cells
    Eissenberg LG, Goldman WE
    Baillière's Clinical Infectious Diseases 1994;1:265-283
  • Histoplasma Variation and Adaptive Strategies for Parasitism: New Perspectives on Histoplasmosis
    Eissenberg LG, Goldman WE
    Clin Microbiol Rev 1991 Oct;4(4):411-21
  • Fusion of Lysosomes With Phagosomes Containing Histoplasma Capsulatum: Use of Fluoresceinated Dextran
    Eissenberg LG, Goldman WE
    Adv Exp Med Biol 1988;239:53-61

Recent Abstracts

  • Combined Targeting of CXCR2 and VLA4 Results in Rapid and Synergistic Mobilization of Hematopoietic Stem and Progenitor Cells in Mice
    Karpova D, Rettig MP, Eissenberg LG, Ritchey J, Holt M, Heier RF, Arnettt SD, Meyers MJ, Griggs DW, Ruminski PG, Morrow D, DiPersio, JF
    December 3-6, 2016, San Diego, American Society for Hematology 58th Annual Meeting
  • In Vitro and in Vivo Killing of AML Using Tetravalent Bispecific CD33/CD3 TandAbs
    Eissenberg LG, Ritchey JK, Fox JA, Reusch U, Knackmuss S, Guenot J, DiPersio JF
    Abstract 3057, May 29-June 2, 2015, Chicago, American Society of Clinical Oncologists Annual Meeting